Carlyle’s Global Credit platform has provided a €250m preferred equity investment to Sanoptis, a European ophthalmology services group, to accelerate growth and drive further M&A activity.
Sanoptis, majority-owned by Groupe Bruxelles Lambert (GBL), operates over 450 locations across Germany, Switzerland, Italy, Spain, Austria, and Greece, delivering 3.3 million treatments annually through a network of approximately 4,700 employees.
The capital will support continued European expansion and investment in advanced medical technologies and treatments and aligns with Carlyle Global Credit’s strategy of providing flexible, privately negotiated capital solutions to high-quality businesses.
As of December 2024, the platform manages $192bn in assets. The deal follows the final close of Carlyle Credit Opportunities Fund III (CCOF III) in December, which raised $7bn in investable capital.
Jefferies acted as sole financial adviser to Sanoptis and GBL on the transaction.
